142 related articles for article (PubMed ID: 33529584)
1. Overlapping Immunohistochemical Features of Adenocarcinoma of the Nonpigmented Ciliary Body Epithelium and Renal Cell Carcinoma.
Hanbazazh M; Barrantes PC; DeVience E; Rana BA; Jadhav N; Gyure K; Grossniklaus HE; Thuro BA; Henneberry J; Milman T; Eagle RC; Shields CL; Shields JA; Dryja TP
Am J Ophthalmol; 2021 Jun; 226():191-200. PubMed ID: 33529584
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of PAX8 Immunohistochemistry in Adult Intraocular Tumor Diagnosis.
Mudhar HS; Milman T; Eagle RC; Sanderson T; Pheasey L; Paine S; Salvi S; Rennie IG; Rundle P; Shields CL; Shields JA
Ophthalmology; 2021 May; 128(5):765-778. PubMed ID: 33002562
[TBL] [Abstract][Full Text] [Related]
3. Adenocarcinoma of the nonpigmented ciliary epithelium: report of two cases with immunohistochemical findings.
Terasaki H; Nagasaka T; Arai M; Harada T; Miyake Y
Graefes Arch Clin Exp Ophthalmol; 2001 Nov; 239(11):876-81. PubMed ID: 11789870
[TBL] [Abstract][Full Text] [Related]
4. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system.
Carvalho JC; Thomas DG; McHugh JB; Shah RB; Kunju LP
Histopathology; 2012 Mar; 60(4):597-608. PubMed ID: 22260386
[TBL] [Abstract][Full Text] [Related]
5. Acquired neoplasms of the nonpigmented ciliary epithelium (adenoma and adenocarcinoma).
Shields JA; Eagle RC; Shields CL; De Potter P
Ophthalmology; 1996 Dec; 103(12):2007-16. PubMed ID: 9003334
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical Panel for Differentiating Renal Cell Carcinoma with Clear and Papillary Features.
Alshenawy HA
Pathol Oncol Res; 2015 Sep; 21(4):893-9. PubMed ID: 25712789
[TBL] [Abstract][Full Text] [Related]
7. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.
Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD
Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047
[TBL] [Abstract][Full Text] [Related]
8. [Expression of carbonic anhydrase IX, PAX2 and PAX8 and their association with clinicopathologic characteristics in renal epithelial tumors].
Zhang W; Yu WJ; Xia Y; Liu Y; Liu XL; Zhuang J; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):442-5. PubMed ID: 24246861
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical profile of renal cell tumours].
Gutiérrez Olivares VM; González Torres LM; Hunter Cuartas G; Niebles De la Hoz MC
Rev Esp Patol; 2019; 52(4):214-221. PubMed ID: 31530404
[TBL] [Abstract][Full Text] [Related]
10. Role Of Immunohistochemistry In Subtyping Renal Cell Carcinomas With Overlapping Morphological Features.
Tariq N; Mamoon N; Haroon A; Ali Z; Ahmad IN
J Ayub Med Coll Abbottabad; 2018; 30(3):325-332. PubMed ID: 30465359
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution.
Paner GP; Srigley JR; Radhakrishnan A; Cohen C; Skinnider BF; Tickoo SK; Young AN; Amin MB
Am J Surg Pathol; 2006 Jan; 30(1):13-9. PubMed ID: 16330937
[TBL] [Abstract][Full Text] [Related]
12. Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.
Bing Z; Lal P; Lu S; Ziober A; Tomaszewski JE
Ann Diagn Pathol; 2013 Feb; 17(1):58-62. PubMed ID: 22898056
[TBL] [Abstract][Full Text] [Related]
13. Role of immunohistochemistry in the evaluation of needle core biopsies in adult renal cortical tumors: an ex vivo study.
Al-Ahmadie HA; Alden D; Fine SW; Gopalan A; Touijer KA; Russo P; Reuter VE; Tickoo SK
Am J Surg Pathol; 2011 Jul; 35(7):949-61. PubMed ID: 21677535
[TBL] [Abstract][Full Text] [Related]
14. Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: a systematic study of 19 immunohistochemical markers in 42 cases.
Yu W; Wang Y; Jiang Y; Zhang W; Li Y
BMC Cancer; 2017 Apr; 17(1):293. PubMed ID: 28449664
[TBL] [Abstract][Full Text] [Related]
15. Clear cell papillary renal cell carcinoma: differential diagnosis and extended immunohistochemical profile.
Williamson SR; Eble JN; Cheng L; Grignon DJ
Mod Pathol; 2013 May; 26(5):697-708. PubMed ID: 23238627
[TBL] [Abstract][Full Text] [Related]
16. CAIX and pax-8 Commonly Immunoreactive in Endolymphatic Sac Tumors: A Clinicopathologic Study of 26 Cases with Differential Considerations for Metastatic Renal Cell Carcinoma in von Hippel-Lindau Patients.
Thompson LDR; Magliocca KR; Andreasen S; Kiss K; Rooper L; Stelow E; Wenig BM; Bishop JA
Head Neck Pathol; 2019 Sep; 13(3):355-363. PubMed ID: 30291511
[TBL] [Abstract][Full Text] [Related]
17. Useful immunohistochemical panel for differentiating clear cell papillary renal cell carcinoma from its mimics.
Pramick M; Ziober A; Bing Z
Ann Diagn Pathol; 2013 Oct; 17(5):437-40. PubMed ID: 23791764
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical diagnosis of renal neoplasms.
Truong LD; Shen SS
Arch Pathol Lab Med; 2011 Jan; 135(1):92-109. PubMed ID: 21204715
[TBL] [Abstract][Full Text] [Related]
19. Pleomorphic adenocarcinomas of the ciliary epithelium. Immunohistochemical and ultrastructural features of 12 cases.
Laver NM; Hidayat AA; Croxatto JO
Ophthalmology; 1999 Jan; 106(1):103-10. PubMed ID: 9917789
[TBL] [Abstract][Full Text] [Related]
20. Cytomorphologic analysis of clear cell papillary renal cell carcinoma: Distinguishing diagnostic features.
Griffin BB; Lin X
Cancer Cytopathol; 2021 Mar; 129(3):192-203. PubMed ID: 33036062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]